Cargando…
Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy
BACKGROUND: Recent studies have validated and confirmed the great potential of nanoscale metal-organic framework (NMOF) in the biomedical field, especially in improving the efficiency of cancer diagnosis and therapy. However, most previous studies only utilized either the metal cluster or the organi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550217/ https://www.ncbi.nlm.nih.gov/pubmed/33116495 http://dx.doi.org/10.2147/IJN.S267321 |
_version_ | 1783592928549011456 |
---|---|
author | Bao, Jianfeng Zu, Xiangyang Wang, Xiao Li, Jinghua Fan, Dandan Shi, Yupeng Xia, Qingchun Cheng, Jingliang |
author_facet | Bao, Jianfeng Zu, Xiangyang Wang, Xiao Li, Jinghua Fan, Dandan Shi, Yupeng Xia, Qingchun Cheng, Jingliang |
author_sort | Bao, Jianfeng |
collection | PubMed |
description | BACKGROUND: Recent studies have validated and confirmed the great potential of nanoscale metal-organic framework (NMOF) in the biomedical field, especially in improving the efficiency of cancer diagnosis and therapy. However, most previous studies only utilized either the metal cluster or the organic ligand of the NMOF for cancer treatments and merely reported limited theranostic functions, which may not be optimized. As a highly designable and easily functionalized material, prospective rational design offers a powerful way to extract the maximum benefit from NMOF for cancer theranostic applications. MATERIALS AND METHODS: A NMOF based on hafnium (Hf) cluster and Mn(III)-porphyrin ligand was rational designed and synthesized as a high-performance multifunctional theranostic agent. The folic acid (FA) was modified on the NMOF surface to enhance the cancer targeting efficacy. The proposed “all-in-one” FA-Hf-Mn-NMOF (fHMNM) was characterized and identified using various analytical techniques. Then, in vitro and in vivo studies were performed to further explore the effects of fHMNM both as the magnetic resonance imaging (MRI)/computed tomography (CT)/photoacoustic imaging (PAI) contrast agent and as the photothermal therapy (PTT)/radiotherapy (RT) agent. RESULTS: A tumour targeting multifunctional fHMNM was successfully synthesized with high performance for MRI/CT/PAI enhancements and image-guided PTT/RT synergistic therapy properties. Compared with the current clinical CT and MR contrast agents, the X-ray attenuation and T(1) relaxation rate of this integrated nanosystem increased 1.7-fold and 3–5-fold, respectively. More importantly, the catalase-like Mn(III)-porphyrin ligand can decompose H(2)O(2) into O(2) in tumour microenvironments to improve the synergistic treatment efficiency of PTT and RT. Significant tumour growth inhibition was achieved in mouse cancer models without obvious damage to the other organs. CONCLUSION: This work highlights the potential of fHMNM as an easily designable material for biomedical applications, could be an effective tool for in vivo detection and subsequent treatment of tumour. |
format | Online Article Text |
id | pubmed-7550217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75502172020-10-27 Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy Bao, Jianfeng Zu, Xiangyang Wang, Xiao Li, Jinghua Fan, Dandan Shi, Yupeng Xia, Qingchun Cheng, Jingliang Int J Nanomedicine Original Research BACKGROUND: Recent studies have validated and confirmed the great potential of nanoscale metal-organic framework (NMOF) in the biomedical field, especially in improving the efficiency of cancer diagnosis and therapy. However, most previous studies only utilized either the metal cluster or the organic ligand of the NMOF for cancer treatments and merely reported limited theranostic functions, which may not be optimized. As a highly designable and easily functionalized material, prospective rational design offers a powerful way to extract the maximum benefit from NMOF for cancer theranostic applications. MATERIALS AND METHODS: A NMOF based on hafnium (Hf) cluster and Mn(III)-porphyrin ligand was rational designed and synthesized as a high-performance multifunctional theranostic agent. The folic acid (FA) was modified on the NMOF surface to enhance the cancer targeting efficacy. The proposed “all-in-one” FA-Hf-Mn-NMOF (fHMNM) was characterized and identified using various analytical techniques. Then, in vitro and in vivo studies were performed to further explore the effects of fHMNM both as the magnetic resonance imaging (MRI)/computed tomography (CT)/photoacoustic imaging (PAI) contrast agent and as the photothermal therapy (PTT)/radiotherapy (RT) agent. RESULTS: A tumour targeting multifunctional fHMNM was successfully synthesized with high performance for MRI/CT/PAI enhancements and image-guided PTT/RT synergistic therapy properties. Compared with the current clinical CT and MR contrast agents, the X-ray attenuation and T(1) relaxation rate of this integrated nanosystem increased 1.7-fold and 3–5-fold, respectively. More importantly, the catalase-like Mn(III)-porphyrin ligand can decompose H(2)O(2) into O(2) in tumour microenvironments to improve the synergistic treatment efficiency of PTT and RT. Significant tumour growth inhibition was achieved in mouse cancer models without obvious damage to the other organs. CONCLUSION: This work highlights the potential of fHMNM as an easily designable material for biomedical applications, could be an effective tool for in vivo detection and subsequent treatment of tumour. Dove 2020-10-08 /pmc/articles/PMC7550217/ /pubmed/33116495 http://dx.doi.org/10.2147/IJN.S267321 Text en © 2020 Bao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Bao, Jianfeng Zu, Xiangyang Wang, Xiao Li, Jinghua Fan, Dandan Shi, Yupeng Xia, Qingchun Cheng, Jingliang Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy |
title | Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy |
title_full | Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy |
title_fullStr | Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy |
title_full_unstemmed | Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy |
title_short | Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy |
title_sort | multifunctional hf/mn-tcpp metal-organic framework nanoparticles for triple-modality imaging-guided ptt/rt synergistic cancer therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550217/ https://www.ncbi.nlm.nih.gov/pubmed/33116495 http://dx.doi.org/10.2147/IJN.S267321 |
work_keys_str_mv | AT baojianfeng multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy AT zuxiangyang multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy AT wangxiao multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy AT lijinghua multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy AT fandandan multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy AT shiyupeng multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy AT xiaqingchun multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy AT chengjingliang multifunctionalhfmntcppmetalorganicframeworknanoparticlesfortriplemodalityimagingguidedpttrtsynergisticcancertherapy |